These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27739029)

  • 21. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
    Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
    Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of HCRP1 leads to upregulation of PD-L1 via STAT3 activation and is of prognostic significance in EGFR-dependent cancer.
    Tomasich E; Topakian T; Heller G; Udovica S; Krainer M; Marhold M
    Transl Res; 2021 Apr; 230():21-33. PubMed ID: 33197651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB; Wang SX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced PHLPP Expression Leads to EGFR-TKI Resistance in Lung Cancer by Activating PI3K-AKT and MAPK-ERK Dual Signaling.
    Wang W; Xia X; Chen K; Chen M; Meng Y; Lv D; Yang H
    Front Oncol; 2021; 11():665045. PubMed ID: 34168988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axis.
    Ye L; Pu C; Tang J; Wang Y; Wang C; Qiu Z; Xiang T; Zhang Y; Peng W
    Respir Res; 2019 May; 20(1):106. PubMed ID: 31142317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway.
    Wang Q; Wu H; Wu Q; Zhong S
    Drug Dev Res; 2023 Aug; 84(5):907-921. PubMed ID: 37070571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
    Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
    J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells.
    Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J
    Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients.
    Yu H; Sun J; Zhao C; Wang H; Liu Y; Xiong J; Chang J; Wang M; Wang W; Ye D; Zhou H; Yu T
    BMC Cancer; 2019 Jul; 19(1):736. PubMed ID: 31345185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
    Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
    Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [High expression of MYH9 inhibits apoptosis of non-small cell lung cancer cells through activating the AKT/c-Myc pathway].
    Liu F; Peng L; Xi J
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Apr; 43(4):527-536. PubMed ID: 37202187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines.
    Shen L; Li Z; Shen S; Niu X; Yu Y; Li Z; Liao M; Chen Z; Lu S
    Lung Cancer; 2012 Dec; 78(3):193-200. PubMed ID: 22985911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ARMC8α promotes proliferation and invasion of non-small cell lung cancer cells by activating the canonical Wnt signaling pathway.
    Xie C; Jiang G; Fan C; Zhang X; Zhang Y; Miao Y; Lin X; Wu J; Wang L; Liu Y; Yu J; Yang L; Zhang D; Xu K; Wang E
    Tumour Biol; 2014 Sep; 35(9):8903-11. PubMed ID: 24894675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
    Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW
    Oncol Rep; 2018 Mar; 39(3):1227-1234. PubMed ID: 29344640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [CacyBP promotes the proliferation and invasion of non-small cell lung cancer].
    Xu YJ; Hu YM; Qin C; Wang F; Cao W; Yu YW; Zhao L; Li J; Chen WQ; Li N; He J
    Zhonghua Zhong Liu Za Zhi; 2021 Sep; 43(9):924-931. PubMed ID: 34530574
    [No Abstract]   [Full Text] [Related]  

  • 37. TMEM229A suppresses non‑small cell lung cancer progression via inactivating the ERK pathway.
    Zhang X; He Y; Jiang Y; Bao Y; Chen Q; Xie D; Yu H; Wang X
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of stomatin protein expression on proliferation and apoptosis of lung cancer cells].
    An HY; Li W; Ma YY; Yuan W; Ma J
    Zhonghua Yi Xue Za Zhi; 2020 Aug; 100(32):2518-2524. PubMed ID: 32829599
    [No Abstract]   [Full Text] [Related]  

  • 39. Upregulation of KLHL17 promotes the proliferation and migration of non-small cell lung cancer by activating the Ras/MAPK signaling pathway.
    Liu Z; Zhao M; Jiang X; Zhang Y; Zhang S; Xu Y; Ren H; Su H; Wang H; Qiu X
    Lab Invest; 2022 Dec; 102(12):1389-1399. PubMed ID: 35978057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. microRNA-99a is downregulated and promotes proliferation, migration and invasion in non-small cell lung cancer A549 and H1299 cells.
    Chen C; Zhao Z; Liu Y; Mu D
    Oncol Lett; 2015 Mar; 9(3):1128-1134. PubMed ID: 25663868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.